Immunofusion (Private limited company)
Immunofusion is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0804.563.629. It was founded on 04-08-2023. Its registered office is in Charleroi. Its main activity is: Scientific research and development. Its annual accounts for 2025 report equity of € -126 049 and a loss of € 42 606. These accounts report 0 full-time equivalents. Addrly gives it a financial health grade of E, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 3 financial years.
Information last updated on 07-10-2026.
Company information
Key figures of Immunofusion
| 2025 | 2024 | 2023 | |
|---|---|---|---|
Profit / lossiWhat the period earned after taxes. A negative amount is a loss. | € -42 606+42 % | € -72 858-436 % | € -13 585 |
EquityiWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company. | € -126 049-51 % | € -83 443-688 % | € -10 585 |
Total assetsiEverything the company owns. Equal to total equity and liabilities, which says how it is financed. | € 32 131+575 % | € 4 761+110 % | € 2 262 |
Gross marginiSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else. | € -42 496+42 % | € -72 670-435 % | € -13 585 |
Employees (FTE)iAverage number of workers over the period, in full-time equivalents. | 0 | - | - |
Financial estimate
Similar companies
Other companies in the same activity in Charleroi.
| Company | Town |
|---|---|
| HENOGEN | 6041 Charleroi |
| ENDO TOOLS THERAPEUTICS | 6041 Charleroi |
| BIO.BE | 6041 Charleroi |
| Santero Therapeutics | 6041 Charleroi |
| OGECO | 6041 Charleroi |
| Brussels South Charleroi BioPark Dev | 6041 Charleroi |
| DNAVision | 6041 Charleroi |
| VIRIDAXIS | 6041 Charleroi |
Frequently asked questions
Is Immunofusion still active? Yes. The Crossroads Bank for Enterprises lists Immunofusion as active.
What is the VAT number of Immunofusion? The VAT number of Immunofusion is BE 0804.563.629.
When was Immunofusion founded? Immunofusion was founded on 04-08-2023.
What is the address of Immunofusion? The current registered office of Immunofusion is Rue Clément Ader 10, 6041 Charleroi.
When did Immunofusion last file annual accounts? The latest annual accounts of Immunofusion were filed on 02-07-2026.
Does Immunofusion file its annual accounts on time? Yes. Immunofusion filed its annual accounts within the legal deadline for each of its last 3 financial years.
How many employees does Immunofusion have? Immunofusion employs 0 full-time equivalents according to its most recent annual accounts.
Is Immunofusion financially healthy? Addrly gives Immunofusion a financial health grade of E, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.
Is Immunofusion profitable? The annual accounts of Immunofusion for 2025 show a loss of € 42 606.
What is the equity of Immunofusion? The equity of Immunofusion was € -126 049 at the close of the 2025 financial year.
Who are the directors of Immunofusion? The annual accounts of Immunofusion record 2 mandates. The names, roles and dates are visible with a free account.
Can Immunofusion receive Peppol e-invoices? Yes. Immunofusion is registered on the Peppol network and can receive structured electronic invoices.
What does Immunofusion do? The main activity of Immunofusion is: Scientific research and development.